Search

everythinglearnresearchcommunity

for

Search:↓

Non-immune dermal cells dominate, epidermal cells increase after day 9, and certain immune cells persist beyond inflammation in wound-induced hair follicle regeneration.

Tiny particles called extracellular vesicles show promise for treating skin conditions and promoting hair growth.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Ovol2 is crucial for hair growth and skin healing by controlling cell movement and growth.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

SM04755 may be an effective topical treatment for psoriasis.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

TRPV3 in skin cells causes inflammation and cell death.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

MSCs and their exosomes may speed up skin wound healing but need more research for consistent use.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Human prenatal skin develops an immune network early on that helps with skin formation and healing without scarring.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

No single treatment is consistently effective for alopecia areata, and more research is needed.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

New treatments for immune disorders caused by FOXN1 deficiency are promising.